| 1 | Name: | Dr. Arnold J. Levine | |
| Institution: | Institute for Advanced Study | ||
| Year Elected: | 2000 | ||
| Class: | 5. The Arts, Professions, and Leaders in Public & Private Affairs | ||
| Subdivision: | 503. Administrators, Bankers and Opinion Leaders from the Public or Private Sectors | ||
| Residency: | Resident | ||
| Living? : | Living | ||
| Birth Date: | 1939 | ||
Arnold Levine discovered the p53 tumor suppressor gene and protein in 1979. He and others went on to show that it was the single most common genetic alteration in human cancers. Over the past 20 years Dr. Levine has led our understanding of how p53 prevents cancers and functions. He has chaired the department of microbiology at the State University of New York, Stony Brook and the department of molecular biology at Princeton University. Between 1998 and 2002 he was the president and chief executive officer of Rockefeller University. He is now a professor emeritus in the School of Natural Sciences at the Institute for Advanced Study in Princeton, New Jersey. A leader in biomedical sciences, Dr. Levine has won numerous prizes in cancer research and holds six honorary degrees. He chaired the National Institutes of Health committee on AIDS Research budgets in 1995-96. His most recent honors are the American Association for Cancer Research's 2008 Kirk A. Landon-AACR Prize for Basic Cancer Research, the Dart/NYU Biotechnology Achievement Award for his work in defining the molecular basis of tumor suppression, the 2009 American Cancer Society's Medal of Honor, and the 2012 Lars Onsager Medal of the Norwegian University of Science and Technology. | |||